Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2009 Dec 11;139(2):395. doi: 10.1016/j.jtcvs.2009.10.005

Outcomes after a Decade of Laparoscopic Giant Paraesophageal Hernia Repair

James D Luketich 1, Katie S Nason 1, Neil A Christie 1, Arjun Pennathur 1, Blair A Jobe 1, Rodney J Landreneau 1, Matthew J Schuchert 1
PMCID: PMC2813424  NIHMSID: NIHMS153602  PMID: 20004917

Abstract

OBJECTIVE

Laparoscopic repair of giant paraesophageal hernia (GPEH) is a complex operation requiring significant laparoscopic expertise. Our objective was to compare our current approach and outcomes with LRGPEH to our previous experience.

METHODS

A retrospective review of patients undergoing non-emergent LRGPEH, stratified by early and current era (1/1997–6/2003 and 7/2003–6/2008) was performed. Surgeon credentialing required a minimally invasive surgical fellowship and/or careful proctoring prior to independent LRGPEH. We evaluated clinical outcomes, barium esophagram and quality-of-life (QoL).

RESULTS

LRGPEH was performed in 662 patients (median age 70, range 19–92); median percent of herniated stomach 70% (range 30–100%). Over time, use of Collis gastroplasty decreased (86% to 53%) as did crural mesh reinforcement (17% to 12%). Current era patients were 50% more likely to have a Charlson comorbidity index score >3. Common complications included pleural effusion (56/652; 9%) and pneumonia (29/653; 4%). Thirty-day mortality was 1.7% (11/662). Mortality and complication rates were stable over time, despite increasing comorbid disease in the current patient cohort. Post-operative GERD-health-related QoL scores were available for 489 patients (30-month median follow-up) with “Good” to “Excellent” results in 90% (438/489). Radiographic recurrence (15.7%) was not associated with symptom recurrence. Reoperation occurred in 3.2% (21/662).

CONCLUSIONS

Over time, we have obtained significant minimally invasive experience and refined our approach to LRGPEH. Perioperative morbidity and mortality remain low, despite increased comorbid disease in the current patient cohort. LRGPEH provided excellent patient satisfaction and symptom improvement, even with small radiographic recurrences. Reoperation rates were comparable to the best open series.

Keywords: Laparoscopy, hernia, hiatal, outcome assessment (health care), recurrence, gastroesophageal reflux, mesh, surgical

Background

Surgical repair of giant paraesophageal hernia (GPEH) is a complex operation and the laparoscopic approach requires advanced laparoscopic expertise. Over time, the feasibility and safety of a laparoscopic approach to GPEH repair has been established.13 However, there is still considerable debate regarding the optimal approach to operative repair, use of routine mesh-reinforcement of the hiatus, the need for an esophageal lengthening procedure and routine fundoplication. Attempts to address these questions have been limited by the small numbers of patients reported in most series.

Over the past decade, we have refined the operation and acquired significant experience in advanced laparoscopic techniques. This study was designed to achieve the following aims: 1) describe the perioperative morbidity and mortality associated with the laparoscopic approach and determine whether these rates have changed over the period of study; 2) evaluate patient and operative factors contributing to an increased risk for perioperative adverse outcomes; 3) assess symptom relief, quality of life, radiographic and symptomatic recurrence and the need for reoperation for symptomatic recurrent hernia during follow-up; and 4) identify potential risk factors for radiographic recurrence and the need for reoperation.

Methods

Patient Selection and Stratification

Patients undergoing elective or urgent laparoscopic repair of GPEH (defined as more than 30% of the stomach herniated into the mediastinum) from January 1, 1997 to June 30, 2008 were included. During this time period, 739 consecutive patients underwent operative repair of GPEH. For this analysis, patients were excluded if they required emergency surgery (n=13), a planned open operation (n=13), or had prior anti-reflux surgery (n=51). Patients requiring hospitalization for hernia-associated symptoms and repaired urgently during the same admission were included in this analysis (n=106; 16%). This retrospective study was approved by our Institutional Review Board.

Patient Demographics and Operative Techniques

Attempted elective or urgent laparoscopic repair of GPEH was performed in 662 consecutive patients. Conversion to an open procedure was necessary in 10 patients (1.5%) for bleeding (n=3), gastric perforation or serosal tear (n=2), adhesions (n=3) or inability to laparoscopically reduce the hernia (n=2). The majority of patients were female (75%; median age 70 years (IQR 19-92)). Body mass index (BMI) ≥35 was documented in 15% of patients. Preoperative history of anemia and/or hematocrit <37 was identified in 41% of patients (271/654). Age-adjusted Charlson comorbidity index (CCI) score was ≥3 for 49% of patients.

Operative Approach

The operative approach to laparoscopic GPEH repair continues to be a “work in progress.” (Details online in Appendix E1.) In this series, esophageal lengthening (Collis gastroplasty) was used in 63%, mesh cruraplasty in 13% and fundoplication (floppy Nissen or partial fundoplasty) in 98%. (Table 1) Operations were performed by 13 thoracic surgeons at the University of Pittsburgh Medical Center. Two senior surgeons (JDL and RJL) performed 56% (n=372) and 17% (n=114) respectively. Under senior supervision, junior surgeons with advanced minimally invasive foregut surgical training (minimum of 25 laparoscopic GPEH repairs) performed the remaining operations. Independent operating required a minimum of 10 successful proctored cases.

Table 1.

Laparoscopic Repair of Giant Paraesophageal Experience: Cohort analysis of early (January 1, 1997 to June 30, 2003) versus current (July 1, 2003–June 30, 2008) experience.

Overall n=662 Early n=202 Current n=460 Crude ORa (95% CI) p-value
Patient Demographics: n (%) n (%) n (%)
Male sex 167 (25) 57 (28) 110 24) 0.8 (0.5, 1.2) 0.24
Age ≥70 years 336 (51) 101 (50) 235 (51) 1.0 (0.8, 1.5)b 0.8
Obese (BMI ≥35) (n=620) 92 (15) 25 (13) 67 (15) 1.2 (0.7, 1.9) 0.6
Charlson Comorbidity Index ≥3b (n=660) 326 (49) 85 (42) 241 (53) 1.5 (1.1, 2.1) 0.01
Preoperative Hernia Size (%)c
  30–49% 280 (42) 78 (39) 202 (44) referent 0.12
  50–74% 87 (13) 23 (11) 64 (14) 1.1 (0.6, 1.9)
  75–99% 148 (22) 52 (26) 96 (21) 0.7 (0.5, 1.1)
  Intrathoracic Stomach 147 (22) 49 (24) 98 (21) 0.8 (0.5, 1.2)
Preoperative Pulmonary Disease 163 (25) 38 (19) 125 (27) 1.6 (1.1, 2.4) 0.02
History of Ever Smoking (n=650) 251 (39) 70 (36) 181 (40) 1.2 (0.8, 1.7) 0.32

Preoperative Symptoms
Chest and/or Abdominal pain (n=655) 353 (54) 102 (51) 251 (55) 1.2 (0.8, 1.7) 0.33
Heartburn (n=650) 431 (66) 118 (59) 313 (70) 1.6 (1.1, 2.3) 0.007
Dysphagia (n=648) 280 (43) 76 (38) 204 (45) 1.3 (0.96, 1.9) 0.09
  Difficulty Swallowing: (n=637)
   Hard Solids 204 (32) 54 (28) 150 (34) 1.4 (0.9, 2.0)e 0.29
   Soft Solids 42 (7) 10 (5) 32 (7) 1.6 (0.8, 3.4)e
   Liquids 21 (3) 8 (4) 13 (3) 0.8 (0.3, 2.0)
Regurgitation (n=655) 388 (59) 110 (55) 278 (61) 1.3 (0.9, 1.8) 0.12
Dyspnea (n=650) 273 (42) 72 (36) 201 (45) 1.4 (1.0, 2.0) 0.03
Bloating (n=634) 195 (31) 57 (29) 138 (32) 1.2 (0.8, 1.7) 0.4
Details of the Operation
Esophageal Lengthening Procedure (n=647) 408 (63) 171 (86) 237 (53) 0.2 (0.1, 0.3) <0.0001
Fundoplication 647 (98) 198 (98) 449 (98) 0.8 (0.3, 2.6) 0.74
Mesh Reinforcement of Crura 88 (13) 35 (17) 53 (12) 0.6 (0.4, 0.99) 0.04
Conversion to open operation 10 (1.5) 2 (1) 8 (1.7) 1.8 (0.4, 8.4) 0.47
Operative Time >260 minutesd (n=630) 182 (29) 85 (42) 97 (21) 0.4 (0.3, 0.5) <0.0001
a

Odds ratio (OR) represents the odds of each variable in the current cohort compared to the early cohort.

b

Charlson comorbidity index (CCI) adjusted for age.

c

Percent of stomach within the mediastinum by barium esophagram, preoperative endoscopy or by intraoperative description. Complete intrathoracic stomach was defined as the entire stomach, including the antrum, herniated into the mediastinum

d

Operation time greater than 260 minutes represents the 75th percentile for operation time for the entire cohort

Database

Using a standardized outcome protocol, data on patients undergoing repair of GPEH were collected retrospectively by trained research personnel and entered into a computerized surgical outcomes database. Data included standard observer-recorded measures, preoperative symptoms, laboratory and radiographic studies, operative details, length of stay (LOS), perioperative mortality, and post-operative adverse outcomes (in-hospital and 30-day).

Symptom assessment questionnaire, barium esophagram, the Gastroesophageal Reflux Disease Health Related Quality of Life (GERD-HRQoL)4, 5 instrument, and the Medical Outcomes Study Short Form-36 (SF-36) Health Survey6 were obtained as described previously.7 The GERD-HRQoL and SF-36 questionnaires were administered in the clinic by trained clinic personnel. Raw GERD-HRQoL scores were converted to categorical variables as follows: excellent: 0 to 5; good: 6 to 10; fair: 11 to 15; and poor: 16 or greater.8 Radiographic recurrence was considered present if >10%, or 2 cm of the stomach was located above the level of the diaphragm on barium esophagram.7, 9 All subsequent esophageal operations were recorded, including reoperation for recurrence (n=21), conversion to Roux-en-Y for obesity (n=3), and esophagectomy for cancer (n=3).

Statistical Analysis

Statistical analysis was performed using STATA SE 10.0 Corp software. Primary outcome variables were 1) perioperative mortality (in-hospital and/or 30-day); and 2) major morbidity (including pneumonia, perioperative hernia recurrence, post-operative leak, pulmonary embolism, need for reoperation and hospital readmission) and LOS. Secondary outcome measures were 1) reoperation for recurrent hernia; 2) radiographic recurrence by barium swallow; and 3) patient-reported outcomes.

Perioperative Morbidity and Mortality Associated with the Laparoscopic Approach

Data were summarized with frequencies and percentages for categorical variables and median with inter-quartile range (IQR) for continuous variables for the entire cohort and then stratified by date of surgery (Early=January 1, 1997–June 30, 2003; Current=July 1, 2003–June 30, 2008). Chi-square, Fischer’s exact, and Student’s t-tests, accounting for unequal variance, were used to describe differences between groups. To determine factors associated with an increased risk for death or major adverse outcomes, crude and adjusted analyses were performed using univariate and multivariate logistic regression. Preoperative and current (most recent) patient-reported outcomes measures were compared using McNemar’s chi-square test for differences in proportions of paired outcomes. Using logistic regression, the odds ratios for radiographic recurrence, reoperation for recurrence and recurrent symptoms associated with the finding of recurrent hiatal hernia on barium esophagram, were determined. Two-sample Wilcoxon rank-sum (Mann-Whitney) test for differences between means was used to calculate the differences in SF-36 summary scores and GERD-HRQoL composite score, stratified by radiographic hernia recurrence.

Missing Data

When clear documentation of the presence or absence of a symptom was not found in retrospective chart review, the data were considered missing. Recognizing that missing data may introduce bias into the analysis, patient factors associated with the probability of data missingness were evaluated using Fisher’s exact test and univariate logistic regression.

Results

Perioperative Morbidity and Mortality after Laparoscopic GPEH Repair

Major adverse outcomes included pneumonia (n=29/653; 4%), congestive heart failure (n=17/654; 2.6%), pulmonary embolism (n=22/653; 3.4%), post-operative leak (n=16/653; 2.5%), perioperative hernia recurrence (n=5/652; 0.8%), need for re-intubation (n=17/655; 2.6%), acute renal failure (n=6/656; 0.9%), cerebral vascular accident (n=4/653; 0.6%), and myocardial infarction (n=6/653; 0.9%). The majority of post-operative leaks occurred in patients who received Collis gastroplasty (14/16; 88%). There were 11 post-operative deaths (11/662; 1.7%). Reoperation within 30-days was performed in 32 patients (32/650; 4.9%) for post-operative leak (n=11), recurrent hernia (n=3), visceral injury (n=2), wound infection requiring incision and drainage (n=2), bleeding (n=2), enteral access for nutrition (n=6), obstructing fundoplication (n=1), small bowel obstruction (n=1), empyema (n=1), retained foreign body(n=1), periesophageal hematoma (n=1), and incisional hernia(n=1).

Laparoscopic Repair of Giant Paraesophageal Hernia in the Current Era

Over the study period, significant shifts in the patient cohort undergoing non-emergent laparoscopic repair, the approach to operation and operative details have occurred. (Table 1) Adverse outcomes in the post-operative period did not differ significantly between the two eras, despite the increased comorbid disease burden in the current cohort. (Data not shown) Current era patients were 60% less likely to undergo reoperation in the immediate postoperative period (OR 0.4, 95% CI 0.2, 0.9) but were 2.3 times more likely to require admission to the ICU than in the early era (OR 2.3, 95% CI 1.5, 3.4). This finding reflects the increased prevalence of comorbid diseases in the current patient population. Median post-operative LOS was 3 days (IQR 2-5) and did not differ significantly between the two eras (early era LOS=3; IQR 2-5 versus current era LOS=4; IQR 2-5, p-value=0.62). Need for hospital readmission after discharge (15/201 (7.5%) in the early era versus 37/458 (8%) in the current era; p= 0.9) and rates of postoperative mortality were similar between the two eras (2/202 (1%) versus 9/460 (2%); p=0.52). The most common reason for readmission was thromboembolic complications (6/52; 11.5%).

Factors that May Contribute to an Increased Odds of Adverse Outcome

Post-operative Mortality

All post-operative deaths occurred in patients with one or more of the following characteristics: age ≥ 70 years, BMI ≥35 and age-adjusted CCI≥3. Mortality at 30-days increased significantly with age (age <60 and 60–69 (0%); age 70–79 (0.9%); age 80 and older (7.8%; p<0.001). Post-operative mortality was also associated with urgency of operation. Patients admitted electively for operative repair had a post-operative mortality rate of 0.5% (3/556) compared to 7.5% for patients undergoing urgent repair (8/106).

Major Non-fatal Adverse Outcomes

In multivariate analysis, patients ≥70 years had a 67% increase (OR 1.67; 95% CI 1.1, 2.7) in the odds of major non-fatal adverse outcomes compared to those <70 years of age. Those with age-adjusted CCI ≥3 had a 66% increase (OR 1.66; 95% CI 1.1, 2.6) in odds of major non-fatal adverse outcome. Odds of post-operative leak were increased 3.8 times (OR 3.82; 95% CI 1.2, 12.7) in patients with BMI ≥35.

Post-operative Length of Stay

Patients with CCI ≥3 had a 2.7 times increased odds of a long hospital stay (defined as ≥5 days: OR=2.7; 95% CI 1.9, 3.8) compared to patients with a CCI <3. There was a trend toward an increased odds of a long hospital stay in the current era (OR 1.4; 95% CI 0.96, 2.0, p-value 0.08) compared to the early era which disappeared when controlled for comorbidities (OR=1.3 for length of stay ≥5 days in the current era; 95% CI 0.86, 1.8, p=0.24).

Symptom Relief and Quality of Life

Recent symptom follow-up was available for 74% of patients (492/662). Median time to follow-up was 30 months (IQR 17-56). There were 170 patients without symptom follow-up (74 are deceased and the remaining 96 declined or were lost to follow-up). Symptom follow-up, validated GERD-HRQoL and SF-36 were more likely to be missing if patients were ≥80 years (p=0.02, p<0.001 and p<0.001, respectively) or had a CCI score of 3 or greater (p=0.01, p=0.01 and p=0.001, respectively). Early era of surgery was significantly associated with missing GERD-HRQoL (p=0.001) and SF-36 (p=0.002) measures.

Symptomatic Relief after Laparoscopic Giant Paraesophageal Hernia Repair

Overall, patients had significant relief of preoperative complaints. (Table 2) The proportion of patients complaining of dysphagia, heartburn, regurgitation, chest and/or abdominal pain, shortness of breath, and aspiration was significantly reduced at current follow-up compared to preoperatively. The proportion of patients complaining of postprandial bloating, however, was unchanged. Of patients complaining of postprandial bloating preoperatively, 33% had persistent symptoms (47/144). In addition, 29% of patients without preoperative bloating (97/337) reported this symptom at their most recent follow-up.

Table 2.

Paired analysis of the relationship between preoperative complaints and current symptoms

Symptom present preoperatively?
Difference in proportion (95% CI) OR (95% CI)a p-valueb
Symptom Currently present? yes no
Dysphagia
yes 76 55 −0.20 (−0.25, −0.14) 0.34 (0.25, 0.47) <0.0001
no 160 246
Heartburn
yes 100 27 −0.44 (−0.49, −0.39) 0.1 (0.07, 0.15) <0.0001
no 261 138
Regurgitation
yes 28 20 −0.48 (−0.53, −0.43) 0.08 (0.05, 0.12) <0.0001
no 261 193
Chest/Abdominal Pain
yes 34 30 −0.42 (−0.47, −0.36) 0.13 (0.09, 0.19) <0.0001
no 228 183
Postprandial Bloating
yes 47 97 −0.02 (−0.08, 0.04) 0.92 (0.69, 1.2) 0.53
no 106 240
Aspiration
yes 2 12 −0.09 (−0.12, −0.05) 0.24 (0.11, 0.45) <0.0001
no 51 387
Shortness of Breath
yes 31 29 −0.29 (−0.34, −0.23) 0.18 (0.12, 0.27) <0.0001
no 163 243
Proton Pump Inhibitors
yes 161 31 −0.41 (−0.46, −0.36) 0.12 (0.08, 0.18) <0.0001
no 249 89
a

Odds ratio (OR) and 95% confidence interval (CI) for having a symptom currently if it was present preoperatively

b

McNemar’s chi-square for analysis of paired variables

Symptoms and the Association with Radiographic Recurrence

There was no difference in rates of symptomatic complaints between patients with a radiographic recurrence and those without radiographic recurrence. A radiographic recurrence was not associated with increased odds of recurrent symptoms. (Table 3)

Table 3.

Comparison of current symptoms between patients with recurrent hernia by barium esophagram and those without recurrent hernia

Radiographic recurrence?b
Symptom Currently present?a (n, %) yes no p-valuec Crude OR (95% CI)
Dysphagia (n=380)
Yes (94, 25%) 15 79 0.13 1.75 (0.89, 3.5)
No (286, 75%) 28 258
Heartburn (n=373)
Yes (101, 27%) 11 90 1.00 0.92 (0.44, 1.9)
No (272, 73%) 32 240
Regurgitation (n=350)
Yes (36, 10%) 6 30 0.28 1.65 (0.64, 4.3)
No (314, 90%) 34 280
Chest/Abdominal Pain (n=330)
Yes (46, 14%) 7 39 0.31 1.58 (0.65, 3.9)
No (284, 86%) 29 255
Postprandial Bloating (n=408)
Yes (122, 30%) 16 106 0.50 1.24 (0.65, 2.67)
No (286, 70%) 31 255
Aspiration (n=318)
Yes (11, 4%) 1 10 1.00 0.92 (0.11, 7.5)
No (307, 96%) 30 277
Shortness of Breath (n=326)
Yes (48, 15%) 7 41 0.31 1.59 (0.65, 3.9)
No (278, 85%) 27 251
Proton Pump Inhibitors (n=369)
Yes (145, 39%) 16 129 1.00 0.99 (0.51, 1.9)
No (224, 61%) 25 199
a

n=number of patients with current symptom assessment

b

Analysis includes only those patients with a barium swallow at least 3 months after initial operation and current symptom complaints. If patients required reoperation (including recurrent hernia, treatment of obesity or esophageal cancer), symptom follow-up was censored to the most recent symptoms prior to reoperation

c

Fischer’s exact test for differences in symptoms between patients with and without radiographic recurrence

Quality of Life: Patient Satisfaction, GERD-HRQoL and SF-36

GERD-HRQoL questionnaires were completed by 489 of 662 patients (74%) at a median time of 30 months from initial operation (IQR 17–56 months). Using the GERD-HRQoL satisfaction scale, patient satisfaction with surgery and current symptoms was high. (Table 4) Radiographic recurrences did not have a significant impact on patient-reported satisfaction (p=0.79) or patient-reported reflux-related quality of life and did not require reoperation in the majority of cases.

Table 4.

Analysis of the impact of radiographic recurrence on GERD-related and overall patient health status at current clinical follow-up

Radiographic Recurrencea
All patients Yes No
Satisfied with Surgery and Current Symptoms n=493
yes 440 (89) 37 (90) 284 (91) 0.79e
no 53 (11) 4 (10) 30 (9)

n=489 n=41 n=312 p-value

GERD-HRQoLb 1 (0–4) 1 (0–4) 2 (0–6) 0.33d
Excellent to Goodc 438 (90) 36 (88) 279 (89) 0.79e
Fair to Poorc 51 (10) 5 (12) 33 (11)

Short-form 36 Health Surveyb n=476 n=40 n=304 p-value

Physical Component Summary (PCS) 51 (40–57) 54 (48–57) 51 (40–57) 0.12d
Mental Component Summary (MCS) 53 (47–56) 53 (49–56) 53 (49–56) 0.62d
a

Includes only patients with current barium esophagram and SF-36 score. Results for patients requiring reoperation were censored at the date of reoperation

b

Results presented as median (IQR)

c

GERD-HRQoL scale: excellent (score 0–5), good (score 6–10), fair (score 11–15), poor (score >15); Results presented as n(%)

d

Two-sample Wilcoxon rank-sum (Mann-Whitney) test

e

Fisher’s exact test for independence

Finally, overall patient satisfaction was assessed using the SF-36 instrument. A complete SF-36 was available for analysis in 476 of 662 patients at a median time from initial operation of 30 months (Table 4; IQR 17-56).

Radiographic and Symptomatic recurrence and the Need for Reoperation

Long-term Radiographic Recurrence and Need for Reoperation

Post-operative barium esophagram was available for 92% of patients (607/662). In 67% (445/662) of patients, the esophagram was obtained 3 months or more after operation. Lack of a barium esophagram obtained 3 months or more after operation was significantly associated with age ≥80 years at time of operation (p=0.04) but not with sex, CCI, BMI, or era of operation. Median time to most recent esophagram was 25 months (IQR 12–46 months). Recurrent hiatal hernia was identified in 70 of 445 patients (15.7%) at a median time of 22 months (IQR 11–39 months). Most radiographic recurrences were small (between 11 and 20% re-herniation of the stomach and/or wrap). Radiographic recurrence and significant symptoms leading to a decision to re-operate occurred in 3.2% of patients (21/662) at a median follow-up of 25 months (IQR 17–43 months), driven primarily by the degree of clinical symptoms.

Risk Factors for Radiographic Recurrence and Need for Reoperation for Recurrence

Age <70 at initial operation was associated with significantly increased odds of radiographic recurrence. Age <70 at initial operation, BMI ≥35, and mesh cruraplasty at initial operation were associated with an increased odds of need for reoperation in crude and adjusted analysis. (Table 5)

Table 5.

Analysis of preoperative risk factors and operative techniques and the risk of reoperation and radiographic recurrence at any time after operation

Recurrent hernia by barium esophagram (n= 445)b Reoperation for recurrent hernia or symptoms
n (%) Crude OR (95% CI) p-value n (%) Crude OR (95% CI) p-value
Overalla 70/445 (15.7) 21/662 (3.2)


Age at initial operation (years)
Less than 70 44/235 (19) referent 0.07 16/326 (4.9) referent 0.01
70 years or greater 26/210 (12) 0.61 (0.36, 1.04) 5/336 (1.5) 0.29 (0.11, 0.81)


Age-Adjusted Charlson Comorbidity Index
Less than 3 (n=334) 42/239 (18) referent 0.25 12/334 (3.6) referent 0.53
3 or greater (n=328) 28/206 (14) 0.74 (0.44, 1.24) 9/326 (2.7) 0.76 (0.3, 1.8)


Body Mass Index
BMI less than 35 50/351 (14) referent 0.09 15/528 (2.8) referent 0.07
BMI 35 or greater 15/67 (22) 1.74 (0.91, 3.3) 6/92 (6.5) 2.4 (0.9, 6.3)


Preoperative Pulmonary Disease
None (n=499) 51/337 (15) referent 0.54 13/499 (2.6) referent 0.15
Present (n=163) 19/108 (18) 1.2 (0.67, 2.13) 8/163 (4.9) 1.93 (0.78, 4.75)


Preoperative Hernia Size (%)c
30 up to 50% 28/189(15) referent 0.60d 12/280 (4.3) referent 0.1
50% up to 75% 10/67 (15) 1.0 (0.46, 2.2) 4/87 (4.6) 1.1 (0.3, 3.4)
75% up to 99% 17/99 (17) 1.2 (0.6, 2.3) 2/148 (1.4) 0.3 (0.1, 1.4)
Complete Intrathoracic Stomach 15/90 (17) 1.2 (0.58, 2.3) 3/147 (2.0) 0.5 (0.1, 1.7)


Type of Fundoplicatione
Partial 16/100 (16) referent 0.89 6/135 (4.4) referent 0.37
Circumferential 52/337 (15) 0.96 (0.52, 1.77) 15/512 (2.9) 0.65 (0.25, 1.7)


Esophageal Lengthening
None (n=212) 24/165 (15) referent 0.65 10/239 (4.2) referent 0.3
Collis gastroplasty (n=383) 44/272 (16) 1.13 (0.66, 1.94) 11/408 (2.7) 0.63 (0.27, 1.5)


Mesh Cruraplasty
None (n=574) 58/387 (15) referent 0.27 13/574 (2.3) referent 0.0007
Mesh (n=88) 12/58 (21) 1.48 (0.74, 2.97) 8/88 (9.1) 4.3 (1.7, 10.8)


Operation Time
Time <260 minutes 46/331 (14) referent 0.07 14/480 (2.9) referent 0.54
Time 260 minutes or more 24/114 (21) 1.65 (0.95, 2.86) 7/182 (3.9) 1.3 (0.5, 3.4)
a

Analysis was also performed for operative time, preoperative pulmonary function testing, history of peptic ulcer disease or diabetes, post-operative complications (leak, pneumonia, acute renal failure, perioperative hernia recurrence, any need for reoperation in the perioperative period) and no association with risk for reoperation and radiographic recurrence was identified.

b

Analysis includes only those patients with barium esophagogram. OR=crude odds ratio for reoperation and radiographic recurrence for each confounding variable.

c

Percentage of stomach within the mediastinum determined by barium esophagography, preoperative endoscopy, or intraoperative description. Complete intrathoracic stomach was defined as the entire stomach, including the antrum, herniated into the mediastinum.

d

p-value for score test for trend of odds

e

Two patients with recurrence did not receive a fundoplication at the initial operation (one gastropexy and one Rouxen-Y gastric bypass)

Discussion

In this single institution, decade-long series of 662 patients, we demonstrate that laparoscopic GPEH repair is feasible, safe, and provides excellent patient satisfaction and symptom resolution despite an increase in patient comorbid conditions over the study period. Laparoscopic repair of GPEH was successfully accomplished in 98.5% of patients with a post-operative mortality rate of 1.7% and major morbidity of 19%. Thromboembolic complications were a significant source of post-operative morbidity, despite routine use of anti-thrombotic compression stockings and subcutaneous heparin. Patient factors that were predictive of increased risk of post-operative death and significant major adverse events were age ≥70 years, BMI ≥35, and CCI score ≥3 and urgent operation. Symptom relief after laparoscopic repair was excellent, with 89% of patients expressing satisfaction with the surgical result at 30 months median clinical follow-up. Importantly, patients with a limited radiographic recurrence compared to those with no radiographic recurrence were equally satisfied with surgery and reported similar GERD-HRQoL outcomes.

When the current era of operation (July 1, 2003–June 30, 2008) was compared to the early era (January 1, 1997 to June 30, 2003), patients were 50% more likely to have significant age-adjusted comorbidities and 60% more likely to have an underlying pulmonary disease. Despite this, the risk of adverse outcome in the current era was the same as in the early era. Operative time and need for reoperation in the immediate post-operative period were significantly less in the current era, reflecting the experience of the surgical team, on-going efforts to refine the operative approach and perioperative patient care.

The only patient characteristic which was associated with a risk for radiographic recurrence and reoperation on multivariate analysis was age younger than 70 years at initial operation. This association with younger age has not been previously described, but one possible hypothesis for this observation is that younger patients are healthier and more active, thereby exerting greater stress on the hiatal repair. This may be a subpopulation where routine crural reinforcement with mesh can lead to improved long-term durability of the repair. Further studies are needed to confirm this association and test this hypothesis.

Laparoscopic Giant Paraesophageal Hernia is comparable to Open Repair

The operative outcomes, long-term symptomatic relief and freedom from radiographic recurrence after laparoscopic repair of GPEH reported here are similar to the outcomes for open repair as reported in the literature. Our operative mortality of 1.7% compares quite well to mortality rates of 0–3.7% that have been reported by Hashemi, Low and others.1012 Interestingly, we found that the operative mortality for elective repair was significantly lower than urgent repair (0.5% versus 7.5%), which contradicts recent studies13 suggesting that mortality for elective and emergent repairs are not substantially different. In our series, elective repair in the hands of experienced surgeons has significantly better outcomes than urgent repair by the same surgeons. This observation warrants further study to more clearly describe this association.

Our radiographic recurrence and symptom outcomes also compared favorably to the outcomes reported for open repair and contrast with the very high rates of radiographic recurrence published in some series of laparoscopic repair.7, 10, 1416. Hashemi and colleagues, in 2000,10 were among the first to publish a high-rate of radiographic recurrence in patients undergoing laparoscopic repair (42% radiographic recurrence rate in 27 patients; median time to barium esophagram 17 months). This sharply contrasted with the 15% radiographic recurrence rate in the open group (median time to barium esophagram 35 months). Symptomatic relief was also worse in the laparoscopic group; 77% of patients reported a good to excellent outcome compared to 88% in their open group. These results should emphasize the need for surgeons to assess their ongoing clinical outcomes and strive for superior outcomes using the surgical approach that works best for their group. In our center, extensive minimally invasive surgical experience and good to excellent results in close to 90% of our patients undergoing laparoscopic repair of their GPEH led to our adoption of this approach in preference over the open approach.

The On-going Debate Regarding Mesh Cruraplasty and Esophageal Lengthening

The use of esophageal lengthening and mesh cruraplasty in repair of GPEH continues to be debated among surgeons and a clear answer does not exist.7, 1721 Hiatal herniation is associated with two distinct processes: axial tension caused by proximal migration of the GEJ in the setting of acquired short esophagus; and radial tension exerted on the hiatal orifice as the hernia enlarges.22 The goal of esophageal lengthening is to eliminate the axial tension exerted on the hiatus by creating an adequate length of intra-abdominal neoesophagus. The goal of mesh cruraplasty is to strengthen the ability of the hiatus to resist radial tension created by the pressure differential between the abdomen and thorax. As such, use of esophageal lengthening and/or mesh cruraplasty is an intraoperative decision and should be made after optimal surgical mobilization of the esophagus and diaphragm. The surgeon then determines the best repair for the patient. The optimal repair may require esophageal lengthening and mesh cruraplasty, one but not the other, or neither.

In our series, use of mesh cruraplasty was not necessary in the opinion of the surgeon in the majority of cases. We believe that two factors are critical to the success of primary crural re-approximation: 1) maintenance of the peritoneal lining over the crura; and 2) complete division of all attachments from the diaphragm to the stomach and spleen. This allows free mobility of the left limb of the crus and facilitates re-approximation without tension. In our experience, we accomplished these the majority of the time and mesh was only required in 13% of cases when the overlying peritoneum had been compromised, leading to exposed muscle fibers of poor integrity or the hiatal opening was unable to be closed without undue tension. The finding in our series that mesh cruroplasty is associated with a significantly increased odds of reoperation for recurrence over time and is not protective against radiographic recurrence reflects the fact that mesh, in our hands, is only used when the crural closure is compromised. Similarly, it may also indicate that the type of mesh and the technical aspects of the cruroplasty are still in evolution and the ideal approach has not been determined.

Conversely, Collis gastroplasty for esophageal lengthening was used in 63% of patients in this series. The majority of our patients had a Type III paraesophageal hernia. Restoring adequate length to the intraabdominal esophagus returns the GEJ to the abdomen and releases the axial tension created by the shortened esophagus, thereby minimizing the axial forces exerted on the hiatal repair. While the use of esophageal lengthening has decreased over time in our series, in our opinion, this is due to the increased experience and success of extended mediastinal mobilization. Extended mobilization may obviate the need for an esophageal lengthening procedure in some patients with mild to moderate shortening or, at least limit the length of the Collis gastroplasty to a shorter segment. This is clearly an important component of the repair and every effort should be made to strive for adequate esophageal length using laparoscopic esophageal mobilization to the maximal degree prior to determining if a Collis gastroplasty is indicated.

Discussion of Study Limitations

This study has several strengths and limitations. Long-term follow-up on this patient population can be difficult to obtain due to the extremes of age and also to the costs of maintaining a clinical outcomes research team. We present mid-term validated patient-reported outcomes in 74% of patients at a median follow-up of 30 months. Radiographic follow-up at least 3 months after operation was available for 67% of patients at a median follow-up of 25 months. While these numbers are comparable to other series,10, 14, 15, 23, 24 a concerted effort has been made over the past two years to improve our longitudinal care for these patients and clinical pathways, have been instituted at our center to provide routine and standardized follow-up. In spite of these measures, serial time-points were not available for most patients, limiting assessment of the time course for radiographic and/or symptom recurrence.

The degree of missing data for the outcomes measured in this study is also a limitation of the study. When factors associated with missing data were analyzed, we found that patients of who were 80 years or older at the time of operation, those with significant comorbid illness and early era of operation were more likely to be missing follow-up symptom questionnaires and validated quality of life studies. Octogenarians were also more likely to be missing a barium esophagram obtained at least 3 months after operation. This degree of missing data introduces bias into the analysis that must be taken into consideration. For example, the percentage of patients complaining of postoperative dysphagia may be under-estimated by the findings of study given that elderly patients are more likely to experience dysphagia than are younger patients. It is also possible that the increased rate of radiographic recurrence in younger patients is reflective of the higher rate of availability of follow-up barium esophagram in this group rather than a true association with increased risk of radiographic recurrence.

Analysis of preoperative symptoms was also limited by the fact that the majority of these data were derived from retrospective review of existing medical records. While most patients had clear prospective documentation of the presence or absence of symptoms such as reflux, regurgitation, dysphagia, and shortness of breath, other symptoms, such as cough and hoarseness were less well-documented. Important post-operative complaints, such as early satiety, diarrhea and excessive flatulence, were rarely assessed preoperatively. These symptoms can be the source of long-term patient dissatisfaction and warrant further study.

Summary

In the largest series to date, we found that laparoscopic repair of GPEH is technically feasible, associated with good to excellent outcomes in close to 90% of patients, and has a low morbidity and mortality in the hands of experienced surgeons. Patients who are obese, older and who have more comorbid illness are at higher risk for adverse post-operative outcomes, but the majority of such cases can still be accomplished laparoscopically with good results. Decisions regarding esophageal lengthening and mesh cruraplasty are best made at the time of operation related to the specific anatomic considerations of the individual patient. Laparoscopic repair of paraesophageal hernia provides excellent patient satisfaction and symptom resolution, with reoperation rates that are comparable to the best open series.10, 25

Supplementary Material

appendix

Acknowledgments

Funding source: This study was supported by the National Institutes of Health grant: NIH/NCRR/CTSA Grant UL1 RR024153

Footnotes

Authorship and Scientific Responsibility: Conception and design: James D. Luketich, Katie S. Nason, Matthew J. Schuchert, Blair A. Jobe

Acquisition of data: Katie S. Nason

Analysis and interpretation of data: James D. Luketich, Katie S. Nason, Matthew J. Schuchert, Blair A. Jobe

Drafting and manuscript revision: James D. Luketich, Katie S. Nason, Neil A. Christie, Arjun Pennathur, Blair A. Jobe, Rodney J. Landreneau, Matthew J. Schuchert

Final approval: James D. Luketich

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Luketich JD, Raja S, Fernando HC, et al. Laparoscopic repair of giant paraesophageal hernia: 100 consecutive cases. Ann Surg. 2000;232(4):608–18. doi: 10.1097/00000658-200010000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pierre AF, Luketich JD, Fernando HC, et al. Results of laparoscopic repair of giant paraesophageal hernias: 200 consecutive patients. Ann Thorac Surg. 2002;74(6):1909–15. doi: 10.1016/s0003-4975(02)04088-2. discussion 1915–6. [DOI] [PubMed] [Google Scholar]
  • 3.Pitcher DE, Curet MJ, Martin DT, et al. Successful laparoscopic repair of paraesophageal hernia. Arch Surg. 1995;130(6):590–6. doi: 10.1001/archsurg.1995.01430060028006. [DOI] [PubMed] [Google Scholar]
  • 4.Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus. 2007;20(2):130–4. doi: 10.1111/j.1442-2050.2007.00658.x. [DOI] [PubMed] [Google Scholar]
  • 5.Velanovich V, Vallance SR, Gusz JR, et al. Quality of life scale for gastroesophageal reflux disease. J Am Coll Surg. 1996;183(3):217–24. [PubMed] [Google Scholar]
  • 6.McHorney CA, Ware JE., Jr Construction and validation of an alternate form general mental health scale for the Medical Outcomes Study Short-Form 36-Item Health Survey. Med Care. 1995;33(1):15–28. doi: 10.1097/00005650-199501000-00002. [DOI] [PubMed] [Google Scholar]
  • 7.Oelschlager BK, Pellegrini CA, Hunter J, et al. Biologic prosthesis reduces recurrence after laparoscopic paraesophageal hernia repair: a multicenter, prospective, randomized trial. Ann Surg. 2006;244(4):481–90. doi: 10.1097/01.sla.0000237759.42831.03. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Whitson BA, Hoang CD, Boettcher AK, et al. Wedge gastroplasty and reinforced crural repair: important components of laparoscopic giant or recurrent hiatal hernia repair. J Thorac Cardiovasc Surg. 2006;132(5):1196–1202. e3. doi: 10.1016/j.jtcvs.2006.07.007. [DOI] [PubMed] [Google Scholar]
  • 9.Nason KS, Luketich JD, Qureshi I, et al. Laparoscopic repair of giant paraesophageal hernia results in long-term patient satisfaction and a durable repair. J Gastrointest Surg. 2008;12(12):2066–75. doi: 10.1007/s11605-008-0712-7. discussion 2075–7. [DOI] [PubMed] [Google Scholar]
  • 10.Hashemi M, Peters JH, DeMeester TR, et al. Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate. J Am Coll Surg. 2000;190(5):553–60. doi: 10.1016/s1072-7515(00)00260-x. discussion 560–1. [DOI] [PubMed] [Google Scholar]
  • 11.Schauer PR, Ikramuddin S, McLaughlin RH, et al. Comparison of laparoscopic versus open repair of paraesophageal hernia. Am J Surg. 1998;176(6):659–65. doi: 10.1016/s0002-9610(98)00272-4. [DOI] [PubMed] [Google Scholar]
  • 12.Altorki NK, Yankelevitz D, Skinner DB. Massive hiatal hernias: the anatomic basis of repair. J Thorac Cardiovasc Surg. 1998;115(4):828–35. doi: 10.1016/S0022-5223(98)70363-0. [DOI] [PubMed] [Google Scholar]
  • 13.Stylopoulos N, Gazelle GS, Rattner DW. Paraesophageal hernias: operation or observation? Ann Surg. 2002;236(4):492–500. doi: 10.1097/00000658-200210000-00012. discussion 500–1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Diaz S, Brunt LM, Klingensmith ME, et al. Laparoscopic paraesophageal hernia repair, a challenging operation: medium-term outcome of 116 patients. J Gastrointest Surg. 2003;7(1):59–66. doi: 10.1016/S1091-255X(02)00151-8. discussion 66–7. [DOI] [PubMed] [Google Scholar]
  • 15.Jobe BA, Aye RW, Deveney CW, et al. Laparoscopic management of giant type III hiatal hernia and short esophagus. Objective follow-up at three years. J Gastrointest Surg. 2002;6(2):181–8. doi: 10.1016/s1091-255x(01)00067-1. discussion 188. [DOI] [PubMed] [Google Scholar]
  • 16.Mattar SG, Bowers SP, Galloway KD, et al. Long-term outcome of laparoscopic repair of paraesophageal hernia. Surg Endosc. 2002;16(5):745–9. doi: 10.1007/s00464-001-8194-7. [DOI] [PubMed] [Google Scholar]
  • 17.Champion JK, Rock D. Laparoscopic mesh cruroplasty for large paraesophageal hernias. Surg Endosc. 2003;17(4):551–3. doi: 10.1007/s00464-002-8817-7. [DOI] [PubMed] [Google Scholar]
  • 18.Granderath FA, Carlson MA, Champion JK, et al. Prosthetic closure of the esophageal hiatus in large hiatal hernia repair and laparoscopic antireflux surgery. Surg Endosc. 2006;20(3):367–79. doi: 10.1007/s00464-005-0467-0. [DOI] [PubMed] [Google Scholar]
  • 19.Granderath FA, Schweiger UM, Pointner R. Laparoscopic antireflux surgery: tailoring the hiatal closure to the size of hiatal surface area. Surg Endosc. 2007;21(4):542–8. doi: 10.1007/s00464-006-9041-7. [DOI] [PubMed] [Google Scholar]
  • 20.Johnson JM, Carbonell AM, Carmody BJ, et al. Laparoscopic mesh hiatoplasty for paraesophageal hernias and fundoplications: a critical analysis of the available literature. Surg Endosc. 2006;20(3):362–6. doi: 10.1007/s00464-005-0357-5. [DOI] [PubMed] [Google Scholar]
  • 21.Rathore MA, Andrabi SI, Bhatti MI, et al. Metaanalysis of recurrence after laparoscopic repair of paraesophageal hernia. Jsls. 2007;11(4):456–60. [PMC free article] [PubMed] [Google Scholar]
  • 22.Kahrilas PJ, Kim HC, Pandolfino JE. Approaches to the diagnosis and grading of hiatal hernia. Best Pract Res Clin Gastroenterol. 2008;22(4):601–16. doi: 10.1016/j.bpg.2007.12.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Andujar JJ, Papasavas PK, Birdas T, et al. Laparoscopic repair of large paraesophageal hernia is associated with a low incidence of recurrence and reoperation. Surg Endosc. 2004;18(3):444–7. doi: 10.1007/s00464-003-8823-4. [DOI] [PubMed] [Google Scholar]
  • 24.Rathore MA, Andrabi I, Nambi E, McMurray AH. Intermediate-term results of laparoscopic repair of giant paraesophageal hernia: lack of follow-up esophagogram leads to detection bias. Jsls. 2007;11(3):344–9. [PMC free article] [PubMed] [Google Scholar]
  • 25.Maziak DE, Todd TR, Pearson FG. Massive hiatus hernia: evaluation and surgical management. J Thorac Cardiovasc Surg. 1998;115(1):53–60. doi: 10.1016/s0022-5223(98)70442-8. discussion 61–2. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

appendix

RESOURCES